El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc (c) Prohens Coll, Llucia, et al., 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/222664

Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Genome-wide association studies (GWAS) have revealed the polygenic nature of treatment-resistant schizophrenia TRS. Gene expression imputation allowed the translation of GWAS results into regulatory mechanisms and the construction of gene expression (GReX) risk scores (GReX-RS). In the present study we computed GReX-RS from the largest GWAS of TRS to assess its association with clinical features. We perform transcriptome imputation in the largest GWAS of TRS to find GReX associated with TRS using brain tissues. Then, for each tissue, we constructed a GReX-RS of the identified genes in a sample of 254 genotyped first episode of psychosis (FEP) patients to test its association with clinical phenotypes, including clinical symptomatology, global functioning and cognitive performance. Our analysis provides evidence that the polygenic basis of TRS includes genetic variants that modulate the expression of certain genes in certain brain areas (substantia nigra, hippocampus, amygdala and frontal cortex), which at the same time are related to clinical features in FEP patients, mainly persistence of negative symptoms and cognitive alterations in sustained attention, which have also been suggested as clinical predictors of TRS. Our results provide a clinical explanation of the polygenic architecture of TRS and give more insight into the biological mechanisms underlying TRS.

Citació

Citació

PROHENS COLL, Llucia, RODRÍGUEZ FERRET, Natalia, GONZÀLEZ SEGURA, Àlex, MARTÍNEZ PINTEÑO, Albert, OLIVARES BERJAGA, David, MARTÍNEZ-SERRANO, Irene, GONZÁLEZ, Aitor, MEZQUIDA MATEOS, Gisela, PARELLADA, Mara, CUESTA, Manuel j., BERNARDO ARROYO, Miquel, GASSÓ ASTORGA, Patricia, MAS HERRERO, Sergi. Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk. _Psychiatry Research_. 2024. Vol. 332. [consulta: 7 de gener de 2026]. ISSN: 0165-1781. [Disponible a: https://hdl.handle.net/2445/222664]

Exportar metadades

JSON - METS

Compartir registre